Sarah Mosier

819 total citations
11 papers, 671 citations indexed

About

Sarah Mosier is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Sarah Mosier has authored 11 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Molecular Biology and 4 papers in Virology. Recurrent topics in Sarah Mosier's work include HIV/AIDS drug development and treatment (5 papers), HIV Research and Treatment (4 papers) and Signaling Pathways in Disease (3 papers). Sarah Mosier is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), HIV Research and Treatment (4 papers) and Signaling Pathways in Disease (3 papers). Sarah Mosier collaborates with scholars based in United States, United Kingdom and Maldives. Sarah Mosier's co-authors include Michael Greenberg, Francis V. Chisari, Barbara Rehermann, C Pasquinelli, Lei Jin, Sherry Stanfield-Oakley, Thomas J. Matthews, Prakash Sista, Miklos Salgo and K.M.J. Menon and has published in prestigious journals such as Journal of Clinical Investigation, Biochemistry and Journal of Virology.

In The Last Decade

Sarah Mosier

11 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Mosier United States 9 413 402 192 155 148 11 671
Richard Trauger United States 15 310 0.8× 213 0.5× 18 0.1× 96 0.6× 119 0.8× 36 536
Mary Soliman United States 5 525 1.3× 374 0.9× 76 0.4× 156 1.0× 102 0.7× 8 659
Anni Winckelmann Denmark 12 718 1.7× 544 1.4× 28 0.1× 154 1.0× 198 1.3× 20 938
Caitlyn Linde United States 11 384 0.9× 197 0.5× 43 0.2× 138 0.9× 193 1.3× 13 662
Malgorzata Simm United States 15 339 0.8× 187 0.5× 89 0.5× 171 1.1× 158 1.1× 26 621
Natalia Laufer Argentina 17 344 0.8× 233 0.6× 208 1.1× 299 1.9× 106 0.7× 61 757
L Mathiesen Denmark 14 257 0.6× 158 0.4× 78 0.4× 231 1.5× 129 0.9× 21 571
Rebecca Sabbe United States 8 378 0.9× 245 0.6× 58 0.3× 130 0.8× 90 0.6× 9 560
Emilia Falkowska United States 8 449 1.1× 147 0.4× 130 0.7× 159 1.0× 190 1.3× 10 617
Marina Korneyeva United States 5 525 1.3× 566 1.4× 68 0.4× 56 0.4× 99 0.7× 7 702

Countries citing papers authored by Sarah Mosier

Since Specialization
Citations

This map shows the geographic impact of Sarah Mosier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Mosier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Mosier more than expected).

Fields of papers citing papers by Sarah Mosier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Mosier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Mosier. The network helps show where Sarah Mosier may publish in the future.

Co-authorship network of co-authors of Sarah Mosier

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Mosier. A scholar is included among the top collaborators of Sarah Mosier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Mosier. Sarah Mosier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hopkins, Sam, Douglas M. Heuman, Jacob Lalezari, et al.. (2012). The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection. Journal of Hepatology. 57(1). 47–54. 71 indexed citations
2.
Peel, Michael, Keqiang Li, Bernard Scorneaux, et al.. (2011). SCY-641 - A Water-Soluble Cyclophilin Inhibitor for the Treatment of Dry Eye Disease. Investigative Ophthalmology & Visual Science. 52(14). 4324–4324. 2 indexed citations
3.
Houck, David R., et al.. (2010). Synthesis and biological evaluation of [d-lysine]8cyclosporin A analogs as potential anti-HCV agents. Bioorganic & Medicinal Chemistry Letters. 20(22). 6542–6546. 14 indexed citations
4.
5.
Wilson, Karen L., Lei Jin, Sherry Stanfield-Oakley, et al.. (2008). Impact of the Enfuvirtide Resistance Mutation N43D and the Associated Baseline Polymorphism E137K on Peptide Sensitivity and Six-Helix Bundle Structure. Biochemistry. 47(25). 6662–6670. 27 indexed citations
6.
Xu, Li, Anton Pozniak, Adrian Wildfire, et al.. (2005). Emergence and Evolution of Enfuvirtide Resistance following Long-Term Therapy Involves Heptad Repeat 2 Mutations within gp41. Antimicrobial Agents and Chemotherapy. 49(3). 1113–1119. 139 indexed citations
7.
Mosier, Sarah, Lei Jin, Thomas Melby, et al.. (2005). Impact of Human Immunodeficiency Virus Type 1 gp41 Amino Acid Substitutions Selected during Enfuvirtide Treatment on gp41 Binding and Antiviral Potency of Enfuvirtide In Vitro. Journal of Virology. 79(19). 12447–12454. 107 indexed citations
8.
Sista, Prakash, Lei Jin, Sarah Mosier, et al.. (2004). Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates. AIDS. 18(13). 1787–1794. 127 indexed citations
9.
Dollenmaier, G, Sarah Mosier, Frank Scholle, et al.. (2001). Membrane-Associated Respiratory Syncytial Virus F Protein Expressed from a Human Rhinovirus Type 14 Vector Is Immunogenic. Virology. 281(2). 216–230. 8 indexed citations
10.
Rehermann, Barbara, C Pasquinelli, Sarah Mosier, & Francis V. Chisari. (1995). Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection.. Journal of Clinical Investigation. 96(3). 1527–1534. 98 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Trauger Breakdown of academic impact, for papers by Mary Soliman Breakdown of academic impact, for papers by Anni Winckelmann Breakdown of academic impact, for papers by Caitlyn Linde Breakdown of academic impact, for papers by Malgorzata Simm Breakdown of academic impact, for papers by Natalia Laufer Breakdown of academic impact, for papers by L Mathiesen Breakdown of academic impact, for papers by Rebecca Sabbe Breakdown of academic impact, for papers by Emilia Falkowska Breakdown of academic impact, for papers by Marina Korneyeva
Rankless by CCL
2026